Can Anti–Tumor Necrosis Factor Therapies Be Stopped in Patients with Rheumatoid Arthritis?

This article requires registration for full access. NEJM Journal Watch articles published within the last six months are available to subscribers only. Articles published more than 6 months ago are available to registered users.